Page 11 - Pharmaceutical

Donald Trump signs 'buy American first' pharmaceutical executive order

US President Donald Trump has signed an executive order directing some federal agencies to prioritise purchasing certain drugs and medical materials when made in the United States

Hetero joins long list of firms to launch Covid-19 drug favipiravir

Will sell its oral anitiviral for Rs 59 a pill, Cipla and DRL to launch soon

Glenmark cuts price of Covid drug FabiFlu by 27% within a month of launch

Higher yields and better scale allowed a price cut, said Company

Strides Pharma gets DGCI approval to test potential Covid-19 drug

Glenmark was the first Indian firm to get approval from regulator to conduct trials on Favipiravir tablets, which are otherwise used to treat influenza

Inovio says COVID-19 vaccine produces antibodies in mice, guinea pigs

The company's shares, which have more than quadrupled this year, surged 17.7% to $17.13 in trading before the bell

GST rates and the medical devices industry

Let us use the GST rate regime to build up a strong domestic industry in sectors like pharmaceuticals and medical devices that can play to our strengths in labour-intensive production

Covid-19 throws up drug supply opportunity for Ipca, other pharma firms

Sun Pharma, Dr Reddy's, Torrent Pharma, Cipla, Cadila Healthcare and Natco Pharma would also benefit from malaria drug supplies, Alembic Pharma from azithromycin sales

Divi's Laboratories begins commercial production at Visakhapatnam unit

Divi's Laboratories, established in Hyderabad, is a pharmaceutical company with two manufacturing units

Laudable move by Pharmexcil

The Pharmexcil came up with clarifications for its members and representations to the government highlighting some difficulties

NPPA allows differential price for Meril's biodegradable cardiac stent

The National Pharmaceutical Pricing Authority (NPPA) invoked the para 32 (ii) of the Drug Price Control Order, 2013 to grant the exemption to the indigenously developed stent

Regulatory woes resurface for Indian pharma companies as stocks fall

Concerns over US sales are diluting positives of strong domestic growth, and have led to a 10 per cent fall in the Nifty Pharma index in one month

Net practice for healing: Netmeds unveils brand campaign with MS Dhoni

That the app was noted, and was able to hit the right chord was evident from the two million downloads that it received from the day it was launched

Global pharmaceutical packaging market to reach $ 158 billion by 2025

Emerging economies such as India, China, Brazil, etc to drive this growth, says Grand View Research

Intrexon & Johnson Matthey team up for production of peptide-based APIs

Though peptide-based APIs are highly useful, they are often costly & difficult to produce

Soon, Jan Aushadhi stores to open at railway stations

Govt plans to utilise railway's infrastructure to increase accessibility of affordable generic drugs

Italian firm Olon buys Ricerca Biosciences' chemical division

Acquisition strengthens service offering of Olon SpA for research and manufacturing

Unichem Laboratories aims $ 100 mn revenue from US

For this, the company will focus on differentiated complex generics, which are difficult to produce

JSR Corp arm KBI Biopharma to invest $ 30 mn to expand two facilities in US

It will expand biopharmaceutical manufacturing capacity at both its Durham and Boulder facilities

Bal Pharma to close down parenterals & IV fluids facility at Pune

Decision was taken as part of its restructuring exercise undertaken to streamline its operations

Pharmaceutical packaging equipment market to reach $ 8.24 billion by 2022

Need for stringent regulatory compliances is driving this market, says MarketsandMarkets report